Showing 1 - 10 of 31,866
This comment was filed with the Department of Justice Antitrust Division on December 31, 2009, as "Comments Regarding Agriculture and Antitrust Enforcement Issues in Our 21st Century Economy" in response to the DOJ/USDA request for public comments for the agencies' joint workshops on antitrust...
Persistent link: https://www.econbiz.de/10014197943
Dramatic recent expansion of intellectual property protection in the field of biotechnology has led to concerns that … source principles to biotechnology research and development. It argues that open source biotechnology is both desirable and …
Persistent link: https://www.econbiz.de/10014063886
Fledgling efforts exist to establish open-source projects in biotechnology. Following copyleft, participants agree that … for the public benefit. In addition, although open source biotechnology may decrease some downstream economic rewards, it …
Persistent link: https://www.econbiz.de/10014071830
property as a package) could be used as an institution to facilitate technology transactions in biotechnology. Patent pools … have been used with success in the consumer electronics and other sectors but they are untested in biotechnology despite … this industry. The first is that the current antitrust requirements are difficult to meet in biotechnology. The second is …
Persistent link: https://www.econbiz.de/10014206748
This paper examines how a radical technological innovation affects alliance formation of firms and subsequent network structures. We use longitudinal data of interfirm R&D collaborations in the biopharmaceutical industry in which a new technological regime is established. Our findings suggest...
Persistent link: https://www.econbiz.de/10011372508
open innovation within technology clusters. Strategic partnerships in the biotechnology industry allow new technology based … partnerships and open innovation on the success of new biotechnology firms in Belgium by developing multiple case studies of firms … in regional biotechnology clusters. A longitudinal follow up of the Belgian biotech startup ecosystem is presented. We …
Persistent link: https://www.econbiz.de/10011325693
In this paper, we examine the determinants of control rights in technology strategic alliances between biotechnology … firms and pharmaceutical corporations, as well as with other biotechnology firms. We undertake three clinical studies and an …
Persistent link: https://www.econbiz.de/10013224324
Using data on over 900 firms for the period 1988-2000, we estimate the effect on phase-specific biotech and pharmaceutical R&D success rates of a firm's overall experience, its experience in the relevant therapeutic category; the diversification of its experience, and alliances with large and...
Persistent link: https://www.econbiz.de/10013233843
Persistent link: https://www.econbiz.de/10013204545
Persistent link: https://www.econbiz.de/10009736422